Annual CFI
$10.58 M
-$71.85 M-87.16%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual cash flow from investing activities is $10.58 million, with the most recent change of -$71.85 million (-87.16%) on December 31, 2023.
- During the last 3 years, MCRB annual CFI has risen by +$169.47 million (+106.66%).
- MCRB annual CFI is now -90.58% below its all-time high of $112.32 million, reached on December 31, 2018.
Performance
MCRB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$141.14 M
+$139.84 M+10740.48%
September 30, 2024
Summary
- As of February 7, 2025, MCRB quarterly cash flow from investing activities is $141.14 million, with the most recent change of +$139.84 million (+10740.48%) on September 30, 2024.
- Over the past year, MCRB quarterly CFI has increased by +$142.02 million (+16193.84%).
- MCRB quarterly CFI is now at all-time high.
Performance
MCRB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$141.51 M
+$142.94 M+9967.92%
September 30, 2024
Summary
- As of February 7, 2025, MCRB TTM cash flow from investing activities is $141.51 million, with the most recent change of +$142.94 million (+9967.92%) on September 30, 2024.
- Over the past year, MCRB TTM CFI has increased by +$130.92 million (+1237.23%).
- MCRB TTM CFI is now at all-time high.
Performance
MCRB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MCRB Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.2% | +10000.0% | +1237.2% |
| 3 y3 years | +106.7% | +2281.8% | +71.7% |
| 5 y5 years | -90.6% | +2281.8% | +71.7% |
MCRB Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.2% | at low | at high | +7954.4% | at high | +9967.9% |
| 5 y | 5-year | -87.2% | +106.7% | at high | +227.6% | at high | +174.8% |
| alltime | all time | -90.6% | +106.7% | at high | +227.6% | at high | +174.8% |
Seres Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $141.14 M(>+9900.0%) | $141.51 M(<-9900.0%) |
| Jun 2024 | - | $1.30 M(-2200.0%) | -$1.43 M(-118.4%) |
| Mar 2024 | - | -$62.00 K(-92.9%) | $7.78 M(-26.5%) |
| Dec 2023 | $10.58 M(-87.2%) | -$877.00 K(-51.2%) | $10.58 M(-39.1%) |
| Sep 2023 | - | -$1.80 M(-117.1%) | $17.39 M(-70.7%) |
| Jun 2023 | - | $10.52 M(+284.0%) | $59.31 M(-17.8%) |
| Mar 2023 | - | $2.74 M(-53.8%) | $72.19 M(-12.4%) |
| Dec 2022 | $82.43 M(+28.6%) | $5.93 M(-85.2%) | $82.43 M(-8.1%) |
| Sep 2022 | - | $40.13 M(+71.5%) | $89.69 M(+20.1%) |
| Jun 2022 | - | $23.40 M(+80.4%) | $74.67 M(-23.6%) |
| Mar 2022 | - | $12.97 M(-1.6%) | $97.80 M(+52.6%) |
| Dec 2021 | $64.09 M(-140.3%) | $13.19 M(-47.5%) | $64.09 M(-362.3%) |
| Sep 2021 | - | $25.11 M(-46.0%) | -$24.43 M(-84.7%) |
| Jun 2021 | - | $46.53 M(-324.4%) | -$160.19 M(-15.3%) |
| Mar 2021 | - | -$20.74 M(-72.5%) | -$189.07 M(+19.0%) |
| Dec 2020 | -$158.89 M(+420.6%) | -$75.33 M(-31.9%) | -$158.89 M(+101.4%) |
| Sep 2020 | - | -$110.64 M(-726.8%) | -$78.90 M(+2735.2%) |
| Jun 2020 | - | $17.65 M(+87.0%) | -$2.78 M(-86.6%) |
| Mar 2020 | - | $9.44 M(+102.8%) | -$20.77 M(-31.9%) |
| Dec 2019 | -$30.52 M | $4.65 M(-113.5%) | -$30.52 M(+71.7%) |
| Sep 2019 | - | -$34.52 M(>+9900.0%) | -$17.77 M(-147.7%) |
| Jun 2019 | - | -$341.00 K(+11.4%) | $37.29 M(-49.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$306.00 K(-101.8%) | $73.98 M(-34.1%) |
| Dec 2018 | $112.32 M(+101.6%) | $17.40 M(-15.3%) | $112.32 M(+7.8%) |
| Sep 2018 | - | $20.54 M(-43.5%) | $104.22 M(+4.6%) |
| Jun 2018 | - | $36.35 M(-4.4%) | $99.60 M(+23.4%) |
| Mar 2018 | - | $38.03 M(+309.1%) | $80.75 M(+45.0%) |
| Dec 2017 | $55.70 M(-184.9%) | $9.30 M(-41.6%) | $55.70 M(-15.6%) |
| Sep 2017 | - | $15.92 M(-9.0%) | $66.00 M(+17.8%) |
| Jun 2017 | - | $17.49 M(+34.7%) | $56.04 M(-179.7%) |
| Mar 2017 | - | $12.99 M(-33.7%) | -$70.32 M(+7.2%) |
| Dec 2016 | -$65.59 M(-52.2%) | $19.59 M(+228.8%) | -$65.59 M(-5.5%) |
| Sep 2016 | - | $5.96 M(-105.5%) | -$69.39 M(-59.4%) |
| Jun 2016 | - | -$108.87 M(-714.3%) | -$171.10 M(+185.5%) |
| Mar 2016 | - | $17.72 M(+12.2%) | -$59.94 M(-56.3%) |
| Dec 2015 | -$137.13 M(>+9900.0%) | $15.80 M(-116.5%) | -$137.13 M(-10.5%) |
| Sep 2015 | - | -$95.76 M(-4272.4%) | -$153.31 M(+164.9%) |
| Jun 2015 | - | $2.29 M(-103.9%) | -$57.86 M(-4.3%) |
| Mar 2015 | - | -$59.47 M(>+9900.0%) | -$60.49 M(+5384.3%) |
| Dec 2014 | -$1.10 M(+499.5%) | -$374.00 K(+18.7%) | -$1.10 M(+51.3%) |
| Sep 2014 | - | -$315.00 K(-5.7%) | -$729.00 K(+76.1%) |
| Jun 2014 | - | -$334.00 K(+317.5%) | -$414.00 K(+417.5%) |
| Mar 2014 | - | -$80.00 K | -$80.00 K |
| Dec 2013 | -$184.00 K(-42.3%) | - | - |
| Dec 2012 | -$319.00 K | - | - |
FAQ
- What is Seres Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Seres Therapeutics?
- What is Seres Therapeutics annual CFI year-on-year change?
- What is Seres Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Seres Therapeutics?
- What is Seres Therapeutics quarterly CFI year-on-year change?
- What is Seres Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Seres Therapeutics?
- What is Seres Therapeutics TTM CFI year-on-year change?
What is Seres Therapeutics annual cash flow from investing activities?
The current annual CFI of MCRB is $10.58 M
What is the all time high annual CFI for Seres Therapeutics?
Seres Therapeutics all-time high annual cash flow from investing activities is $112.32 M
What is Seres Therapeutics annual CFI year-on-year change?
Over the past year, MCRB annual cash flow from investing activities has changed by -$71.85 M (-87.16%)
What is Seres Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of MCRB is $141.14 M
What is the all time high quarterly CFI for Seres Therapeutics?
Seres Therapeutics all-time high quarterly cash flow from investing activities is $141.14 M
What is Seres Therapeutics quarterly CFI year-on-year change?
Over the past year, MCRB quarterly cash flow from investing activities has changed by +$142.02 M (+16193.84%)
What is Seres Therapeutics TTM cash flow from investing activities?
The current TTM CFI of MCRB is $141.51 M
What is the all time high TTM CFI for Seres Therapeutics?
Seres Therapeutics all-time high TTM cash flow from investing activities is $141.51 M
What is Seres Therapeutics TTM CFI year-on-year change?
Over the past year, MCRB TTM cash flow from investing activities has changed by +$130.92 M (+1237.23%)